{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:11:55Z","timestamp":1791220315858,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.pupt.2013.01.003","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T18:34:47Z","timestamp":1358361287000},"page":"332-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Parveen","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umakant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Dobhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarman","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2013.01.003_bib1","unstructured":"Revised National TB Control Programme. TB India 2011 RNTCP annual status report. Retrieved from http:\/\/www.tbcindia.org\/pdfs\/RNTCP%20TB%20India%202011.pdf."},{"key":"10.1016\/j.pupt.2013.01.003_bib2","unstructured":"World Health Organisation. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Retrieved from http:\/\/whqlibdoc.who.int\/hq\/1999\/WHO_CDS_CPC_TB_99.270.pdf."},{"key":"10.1016\/j.pupt.2013.01.003_bib3","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1086\/588292","article-title":"Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment","volume":"46","author":"Molly","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pupt.2013.01.003_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1572-5995(05)80058-4","article-title":"Chemical and biological aspects of iridoid bearing plants of temperate region","volume":"32","author":"Kumar","year":"2005","journal-title":"Stud Nat Prod Chem"},{"key":"10.1016\/j.pupt.2013.01.003_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/jac\/dkl523","article-title":"Synergistic antimycobacterial activities of sesquiterpene lactones from Laurus spp","volume":"59","author":"Luna-Herrera","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pupt.2013.01.003_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1078\/0944-7113-00346","article-title":"Effects of plumieride, an iridoid on spermatogenesis in male albino rats","volume":"11","author":"Gupta","year":"2004","journal-title":"Phytomed"},{"key":"10.1016\/j.pupt.2013.01.003_bib7","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1021\/jo0491408","article-title":"Structural modifications of plumieride isolated from Plumeria bicolor and the effect of these modifications on in\u00a0vitro anticancer activity","volume":"69","author":"Dobhal","year":"2004","journal-title":"J\u00a0Org Chem"},{"key":"10.1016\/j.pupt.2013.01.003_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4103\/0971-5916.91005","article-title":"Antiparasitic activity of plumericin & isoplumericin isolated from Plumeria bicolor against Leishmania donovani","volume":"34","author":"Sharma","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.pupt.2013.01.003_bib9","first-page":"1567","article-title":"Antifungal activity of plumericin and isoplumericin","volume":"6","author":"Singh","year":"2011","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.pupt.2013.01.003_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/np970253e","article-title":"Bioactive iridoids and a new lignan from Allamanda cathartica and Himatanthus fallax from the Suriname rainforest","volume":"60","author":"Abdel-Kader","year":"1997","journal-title":"J\u00a0Nat Prod"},{"key":"10.1016\/j.pupt.2013.01.003_bib11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1248\/cpb.49.1477","article-title":"A\u00a0bioactive spirolactone iridoid and triterpenoids from Himatanthus sucuuba","volume":"49","author":"Wood","year":"2001","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.pupt.2013.01.003_bib12","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/QAD.0b013e3282f125c9","article-title":"High rate of extensively drug-resistant tuberculosis in Indian AIDS patients","volume":"2","author":"Singh","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.pupt.2013.01.003_bib13","series-title":"Public health mycobacteriology. A guide for the level III laboratory","author":"Kent","year":"1985"},{"key":"10.1016\/j.pupt.2013.01.003_bib14","unstructured":"World Health Organisation. Non-commercial culture and drug-susceptibility testing methods for screening of patients at risk of multi drug resistant tuberculosis. Policy statement-2011. Retrieved from http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241501620_eng.pdf."},{"key":"10.1016\/j.pupt.2013.01.003_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-0711-7-15","article-title":"In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay","volume":"7","author":"Sankar","year":"2008","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.pupt.2013.01.003_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jac\/dkn307","article-title":"A\u00a0microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents","volume":"62","author":"Hurdle","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pupt.2013.01.003_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.49.11.176-182.2005","article-title":"Anti-leishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium","volume":"49","author":"Tiuman","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pupt.2013.01.003_bib18","first-page":"71","article-title":"Evaluation of some plant-derived secondary metabolites against sensitive and multidrug-resistant Mycobacterium tuberculosis","volume":"53","author":"Mar\u00eda","year":"2009","journal-title":"J\u00a0Mex Chem Soc"},{"key":"10.1016\/j.pupt.2013.01.003_bib19","first-page":"6683","article-title":"Antimicrobial activity of some medicinal plants used for the treatment of tuberculosis in the Eastern Cape Province, South Africa","volume":"8","author":"Buwa","year":"2009","journal-title":"Afri J Biotech"},{"key":"10.1016\/j.pupt.2013.01.003_bib20","first-page":"77","article-title":"Antimicrobial activities of Plumeria acutifolia","volume":"2","author":"Rasool","year":"2008","journal-title":"J\u00a0Med Plants Res"},{"key":"10.1016\/j.pupt.2013.01.003_bib21","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M211968200","article-title":"Targeting tuberculosis and malaria through inhibition of enoyl reductase","volume":"278","author":"Mack","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2013.01.003_bib22","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1021\/jm0706158","article-title":"Rational design of 5\u2032-thiourea-substituted \u03b1-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacterial growth","volume":"50","author":"Ineke","year":"2007","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pupt.2013.01.003_bib23","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1021\/jo00835a078","article-title":"Reaction of endocyclic \u03b1, \u03b2-unsaturated lactones with thiols","volume":"35","author":"Kupchan","year":"1970","journal-title":"J\u00a0Org Chem"},{"key":"10.1016\/j.pupt.2013.01.003_bib24","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1021\/ja00276a043","article-title":"A\u00a0total synthesis of plumericin, allamcin, and allamandin. Part 1 basic strategy","volume":"108","author":"Trost","year":"1986","journal-title":"J\u00a0Am Chem Soci"},{"key":"10.1016\/j.pupt.2013.01.003_bib25","series-title":"Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs","author":"World Health Organisation","year":"2008"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:28:00Z","timestamp":1761082080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1094553913000059"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.01.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-mycobacterial activity of plumericin and isoplumericin against MDR Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2013.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}